Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom in Plant Deal With Methexis Genomics

Premium

S

AN DIEGO--Industrial genomics company Sequenom announced last week that it reached a collaborative and a commercial agreement with Methexis Genomics of Ghent, Belgium. The companies intend to use their combined technologies to quickly and accurately discover and assess genetic variations, including single-nucleotide polymorphisms in targeted regions of human and plant genomes, and to create and sell commercial products and services utilizing their combined technologies. Methexis has also purchased Sequenom's MassArray system as a platform for its differential sequencing technology for the discovery of genetic variations, such as SNPs.

Hubert Koster, Sequenom's president and CEO said that using Methexis' SNP discovery technology with the mass array system for SNP analysis would create the potential to scan genes for genetic variation with greater speed and accuracy. "This combined with Sequenom's automated SNP assay design and validation capabilities, we believe will lead to highly valuable genomic products that combine discovery, function, and validation of genetic information associated with specific diseases," said Koster.

Methexis Genomics was founded in 1998 to capitalize on the demand to discover genetic variations in viral, bacterial, human, and plant genomes. Methexis' technology is based on a proprietary innovative concept for diagnostic sequencing using mass spectrometry.

Filed under

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.